Clinical Trial Update: Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of miltefosine and an antimony-based therapy for cutaneous leishmaniasis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)
• Sodium stibogluconate (sodium stibogluconate)

Snippet

Sponsor: Foundation Fader | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: TERMINATED